| Title | Hepatobiliary and Pancreatic Diseases International |
| Abbreviation | Hepatobiliary Pancreat. Dis. Int. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Gastroenterology (Q2); Hepatology (Q2) |
| h-index | 53 |
| Overall Rank/Ranking | 7217 |
| SCImago Journal Rank (SJR) | 0.691 |
| Impact Score | 1.89 |
| Publisher | Elsevier (Singapore) Pte Ltd |
| Country | Singapore |
| ISSN | 14993872 |
| Best Quartile | Q2 |
| Coverage History | 2002-2022 |
Hepatobiliary & Pancreatic Diseases International (HBPD INT) publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases. Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Communications, Clinical Summary, Clinical Images and Case Reports. The journal also deals with the basic sciences and experimental work.
Hepatobiliary and Pancreatic Diseases International is a journal covering the technologies/fields/categories related to Gastroenterology (Q2); Hepatology (Q2). It is published by Elsevier (Singapore) Pte Ltd. The overall rank of Hepatobiliary and Pancreatic Diseases International is 7217. According to SCImago Journal Rank (SJR), this journal is ranked 0.691. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 53. The best quartile for this journal is Q2.
The ISSN of Hepatobiliary and Pancreatic Diseases International journal is 14993872. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Hepatobiliary and Pancreatic Diseases International is cited by a total of 682 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Hepatobiliary and Pancreatic Diseases International is 1.89, which is computed in 2023 as per its definition. Hepatobiliary and Pancreatic Diseases International IF is decreased by a factor of 0.1 and approximate percentage change is -5.03% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Hepatobiliary and Pancreatic Diseases International is 1.89. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.89 |
| 2021 | 1.99 |
| 2020 | 2.22 |
| 2019 | 1.86 |
| 2018 | 1.34 |
| 2017 | 1.51 |
| 2016 | 1.67 |
| 2015 | 1.87 |
| 2014 | 1.88 |
Hepatobiliary and Pancreatic Diseases International has an h-index of 53. It means 53 articles of this journal have more than 53 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Hepatobiliary and Pancreatic Diseases International is 14993872. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Hepatobiliary and Pancreatic Diseases International is 7217. According to SCImago Journal Rank (SJR), this journal is ranked 0.691. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.691 |
| 2021 | 0.657 |
| 2020 | 0.846 |
| 2019 | 0.661 |
| 2018 | 0.560 |
| 2017 | 0.711 |
| 2016 | 0.693 |
| 2015 | 0.728 |
| 2014 | 0.599 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 7217 |
| 2021 | 7389 |
| 2020 | 5586 |
| 2019 | 7407 |
| 2018 | 8595 |
| 2017 | 6649 |
| 2016 | 6834 |
| 2015 | 6545 |
| 2014 | 7698 |
Hepatobiliary and Pancreatic Diseases International is published by Elsevier (Singapore) Pte Ltd. It's publishing house is located in Singapore. Coverage history of this journal is as following: 2002-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Hepatobiliary and Pancreatic Diseases International is Hepatobiliary Pancreat. Dis. Int.. This abbreviation ('Hepatobiliary Pancreat. Dis. Int.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Gastroenterology (Q2); Hepatology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Hepatobiliary and Pancreatic Diseases International latest impact IF is 1.89. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.22 (2020) and 1.34 (2018), respectively, in the last 9 years. Moreover, its average IS is 1.8 in the previous 9 years.
The Hepatobiliary and Pancreatic Diseases International has an SJR (SCImago Journal Rank) of 0.691, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.846 in 2020 and the lowest being 0.560 in 2018. Furthermore, the average SJR of the Hepatobiliary and Pancreatic Diseases International over the previous 9-year period stands at 1.8.
The latest h-index of the Hepatobiliary and Pancreatic Diseases International is 53.
The Hepatobiliary and Pancreatic Diseases International is published by the Elsevier (Singapore) Pte Ltd, with its country of publication being the Singapore.
The Hepatobiliary and Pancreatic Diseases International is currently ranked 7217 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5586 in 2020 and its lowest position of 8595 in 2018.
The standard ISO4 abbreviation for the Hepatobiliary and Pancreatic Diseases International is Hepatobiliary Pancreat. Dis. Int..
Hepatobiliary and Pancreatic Diseases International is classified as a journal that the Elsevier (Singapore) Pte Ltd publishes.
The Hepatobiliary and Pancreatic Diseases International encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Hepatobiliary and Pancreatic Diseases International is assigned the following International Standard Serial Numbers (ISSN): 14993872.
The best quartile for the Hepatobiliary and Pancreatic Diseases International is Q2 (2022).
The Hepatobiliary and Pancreatic Diseases International coverage history can be summarized as follows: 2002-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 10343 | Vilnius Gediminas Technical University | 45 | 2.81 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Journal of Business Finance and Accounting | journal | 3221 | Wiley-Blackwell Publishing Ltd | 84 | 3.68 |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Natural Solutions | trade journal | 28581 | Innovision Health Media | 1 | 0.00 |
| Journal of Immigrant and Refugee Studies | journal | 9246 | Routledge | 32 | 1.46 |
| Genes and Nutrition | journal | 6154 | BioMed Central Ltd. | 61 | 3.28 |
| Acta Periodica Technologica | journal | 19470 | University of Novi Sad, Faculty of Technology | 18 | 0.62 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.89 |
| 2021 | 1.99 |
| 2020 | 2.22 |
| 2019 | 1.86 |
| 2018 | 1.34 |
| 2017 | 1.51 |
| 2016 | 1.67 |
| 2015 | 1.87 |
| 2014 | 1.88 |
